Literature DB >> 35611126

Highlights From the 2021 Advances in Inflammatory Bowel Diseases Conference: Commentary.

Gary R Liechtenstein.   

Abstract

Entities:  

Year:  2021        PMID: 35611126      PMCID: PMC9122055     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


× No keyword cloud information.
  52 in total

1.  A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables.

Authors:  C A Siegel; H Horton; L S Siegel; K D Thompson; T Mackenzie; S K Stewart; P W Rice; J M Stempak; S Dezfoli; T Haritunians; A Levy; M Baek; R Milgrom; P S Dulai; S R Targan; M S Silverberg; M C Dubinsky; D P McGovern
Journal:  Aliment Pharmacol Ther       Date:  2015-11-15       Impact factor: 8.171

Review 2.  Optimizing the use of anti-tumor necrosis factor in the management of patients with Crohn's disease.

Authors:  Douglas L Nguyen; Sarah Flores; Kareem Sassi; Matthew L Bechtold; Emily T Nguyen; Nimisha K Parekh
Journal:  Ther Adv Chronic Dis       Date:  2015-05       Impact factor: 5.091

3.  Crohn's disease evaluation and treatment: clinical decision tool.

Authors:  William J Sandborn
Journal:  Gastroenterology       Date:  2014-07-18       Impact factor: 22.682

4.  Long term metabolic consequences of ileal pouch-anal anastomosis for ulcerative colitis.

Authors:  J Kuisma; H Nuutinen; P Luukkonen; H Järvinen; A Kahri; M Färkkilä
Journal:  Am J Gastroenterol       Date:  2001-11       Impact factor: 10.864

5.  Prevalence of cobalamin deficiency in the Framingham elderly population.

Authors:  J Lindenbaum; I H Rosenberg; P W Wilson; S P Stabler; R H Allen
Journal:  Am J Clin Nutr       Date:  1994-07       Impact factor: 7.045

6.  TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India.

Authors:  Narinder Grover; Prateek Bhatia; Antriksh Kumar; Minu Singh; Deepesh Lad; Harshal S Mandavdhare; Jayanta Samanta; Kaushal K Prasad; Usha Dutta; Vishal Sharma
Journal:  BMC Gastroenterol       Date:  2021-08-23       Impact factor: 3.067

7.  Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.

Authors:  William J Sandborn; Brian G Feagan; Geert D'Haens; Douglas C Wolf; Igor Jovanovic; Stephen B Hanauer; Subrata Ghosh; AnnKatrin Petersen; Steven Y Hua; Ji Hwan Lee; Lorna Charles; Denesh Chitkara; Keith Usiskin; Jean-Frederic Colombel; Loren Laine; Silvio Danese
Journal:  N Engl J Med       Date:  2021-09-30       Impact factor: 176.079

8.  Achieving Precision Medicine in Allergic Disease: Progress and Challenges.

Authors:  Steven P Proper; Nurit P Azouz; Tesfaye B Mersha
Journal:  Front Immunol       Date:  2021-08-18       Impact factor: 7.561

9.  Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease.

Authors:  Gareth J Walker; James W Harrison; Graham A Heap; Michiel D Voskuil; Vibeke Andersen; Carl A Anderson; Ashwin N Ananthakrishnan; Jeffrey C Barrett; Laurent Beaugerie; Claire M Bewshea; Andy T Cole; Fraser R Cummings; Mark J Daly; Pierre Ellul; Richard N Fedorak; Eleonora A M Festen; Timothy H Florin; Daniel R Gaya; Jonas Halfvarson; Ailsa L Hart; Neel M Heerasing; Peter Hendy; Peter M Irving; Samuel E Jones; Jukka Koskela; James O Lindsay; John C Mansfield; Dermot McGovern; Miles Parkes; Richard C G Pollok; Subramaniam Ramakrishnan; David S Rampton; Manuel A Rivas; Richard K Russell; Michael Schultz; Shaji Sebastian; Philippe Seksik; Abhey Singh; Kenji So; Harry Sokol; Kavitha Subramaniam; Anthony Todd; Vito Annese; Rinse K Weersma; Ramnik Xavier; Rebecca Ward; Michael N Weedon; James R Goodhand; Nicholas A Kennedy; Tariq Ahmad
Journal:  JAMA       Date:  2019-02-26       Impact factor: 56.272

10.  Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease.

Authors:  Bram Verstockt; Sare Verstockt; Jonas Dehairs; Vera Ballet; Helene Blevi; Willem-Jan Wollants; Christine Breynaert; Gert Van Assche; Séverine Vermeire; Marc Ferrante
Journal:  EBioMedicine       Date:  2019-01-24       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.